Leukemias
ALL, AML, CML, and CLL — induction, maintenance, transplant, and targeted therapy.
Understanding cancer treatment, step by step — from diagnosis to advanced therapies. Our medical oncology services include chemotherapy treatment for solid tumors and blood cancers. Patients evaluating providers should read what to look for when choosing an oncologist — credentials, transplant experience, treatment philosophy, and the questions worth asking before you commit to a care team. If you'd like a fresh read on a diagnosis or treatment plan, our second opinion service for cancer patients reviews your reports independently. For Dr. Madhav's TV and press coverage, visit Media.
Treatment approaches — what we offer. For the disease itself (warning signs, biology, treatment by cancer type), see Cancer Types We Treat.

Systemic cancer treatment, decision-making, and long-term care across the entire journey — chemotherapy, targeted therapy, and immunotherapy for solid tumours.
Explore
Care for leukemia, lymphoma, myeloma, and disorders of the blood and marrow.
Explore
When transplant is needed, how it works, and what the journey really involves.
Explore
How engineered immune cells are used in relapsed or resistant blood cancers.
Explore
What chemotherapy really does, why it continues after response, and how it's safely delivered.
Explore
Structured review of your diagnosis, staging, and proposed plan — with a written summary you can share with your treating oncologist.
ExploreLong-form notes on the questions that matter most — screening, second opinions, treatment decisions, family history.

RASolute 302 at ASCO 2026 moved the pancreatic cancer survival curve for the first time in fifteen years — and the forty-year story behind it.
Read article
A plain-English guide to grade, stage, IHC, and molecular markers — every treatment decision is built from this one document.
Read article
Three questions on a Sunday afternoon. The answers shift your screening calendar by a decade.
Read articleThe pages above describe how we treat. For pages on what we treat — breast, lung, colorectal, prostate, ovarian, head & neck, stomach, cervical — head to the cancer-types library, organised by body site with warning signs, biology, and first-line treatment for each.
Blood cancers, solid tumours, transplant, and advanced cellular therapies — the areas Dr. Madhav Danthala practises day to day.
ALL, AML, CML, and CLL — induction, maintenance, transplant, and targeted therapy.
Hodgkin and non-Hodgkin lymphoma with chemo, immunotherapy, and transplant when needed.
Induction, maintenance, transplant, and relapsed-disease planning.
Breast, lung, GI, gynaecologic, and head & neck — subtype-led systemic therapy.
300+ transplants — autologous, sibling, unrelated, and haploidentical options.
Advanced immune-cell therapies for selected relapsed blood cancers.
Medical oncology covers systemic treatment for solid tumours — chemotherapy, targeted therapy, immunotherapy. Hemato-oncology covers blood cancers like leukemia, lymphoma, and myeloma. A stem cell transplant is a procedure used within hemato-oncology when high-dose chemotherapy or an immune-system reset is needed. Dr. Madhav Danthala practises across all three.
CAR-T uses a patient's own immune cells, re-engineered in a lab to recognise and kill cancer. It is most established in relapsed or resistant blood cancers — B-cell lymphoma, B-cell ALL, and multiple myeloma. It requires a specialised centre and is offered to selected patients after standard treatments have not worked.
Chemotherapy is given in cycles, with the dose and combination tailored to the cancer type, stage, biomarker profile, and the patient's general health. It can be intravenous or oral, in day-care or sometimes at home, and is routinely paired with anti-nausea, growth-factor, and supportive medications.
Use the Second Opinion service, where you upload your pathology, imaging, and current treatment plan. Dr. Madhav reviews the file and issues a written summary you can share with your treating oncologist — confirming the plan or surfacing an alternative.